Skip to content

13F-HR filed by MPM BIOIMPACT LLC

MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 34 holding rows worth $496,602,631.

Accession
0000950123-23-007806
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 34 entries on the cover page, a total value of $496,602,631 stated on the cover page (in dollars after the unit check, H1), rows summing to $496,602,631 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CULLINAN THERAPEUTICS INC230031106COM7,648,268$82,295,364dollars as filed
IVERIC BIO INC46583P102COM1,214,662$47,784,803dollars as filed
CHINOOK THERAPEUTICS INC16961L106COM1,003,406$38,550,859dollars as filed
GERON CORP374163103COM9,191,290$29,504,041dollars as filed
REATA PHARMACEUTICALS INC75615P103CL A234,478$23,907,377dollars as filed
ITEOS THERAPEUTICS INC46565G104COM1,745,943$23,116,285dollars as filed
INTELLIA THERAPEUTICS INC45826J105COM544,639$22,210,378dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM2,950,118$20,768,831dollars as filed
REPARE THERAPEUTICS INC760273102COM1,639,849$17,349,602dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock1,354,368$17,010,862dollars as filed
VERVE THERAPEUTICS INC92539P101COM857,940$16,086,375dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock295,111$15,050,661dollars as filed
REGENXBIO INC75901B107COM656,718$13,127,793dollars as filed
KARUNA THERAPEUTICS INC48576A100COM53,399$11,579,573dollars as filed
INSMED INC COM PAR $.01457669307Stock529,743$11,177,577dollars as filed
XERIS BIOPHARMA HOLDINGS INC98422E103COM3,974,999$10,414,497dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock38,011$8,780,541dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock479,053$8,632,535dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM552,846$8,491,715dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock273,408$7,313,664dollars as filed
WEREWOLF THERAPEUTICS INC95075A107CMN2,388,011$7,283,434dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM761,538$6,853,842dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock93,586$6,725,090dollars as filed
AMICUS THERAPEUTICS INC03152W109COM516,139$6,482,706dollars as filed
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO384,990$6,344,635dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM255,323$6,074,134dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM712,798$5,524,185dollars as filed
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR5,095,912$4,713,719dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM462,500$4,176,375dollars as filed
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK282,332$4,042,994dollars as filed
HARPOON THERAPEUTICS INC41358P106COM3,196,707$2,269,662dollars as filed
INOZYME PHARMA INC45790W108COM326,921$1,820,950dollars as filed
Ventyx Biosciences Inc92332V107Common Stock31,747$1,041,302dollars as filed
ONCORUS INC68236R103COM2,377,031$96,270dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-23-007806this filing2023-08-14acceptance time not in the bulk data set